Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1+ Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Yuxin Liang,Deyuan Zhong,Qinyan Yang,Yuan Tang,Yingying Qin,Yuhao Su,Xiaolun Huang,Jin Shang
DOI: https://doi.org/10.2147/jhc.s453249
2024-02-22
Journal of Hepatocellular Carcinoma
Abstract:Yuxin Liang, 1, &ast Deyuan Zhong, 1, &ast Qinyan Yang, 1 Yuan Tang, 1 Yingying Qin, 2 Yuhao Su, 1 Xiaolun Huang, 1 Jin Shang 1 1 Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China; 2 School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, SAR, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jin Shang; Xiaolun Huang, Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People's Republic of China, Email ; Background: Tumor metastasis is the leading cause of high mortality in hepatocellular carcinoma (HCC). The metastasis-related HCC microenvironment is characterized by high heterogeneity. Single-cell RNA sequencing (scRNA-seq) may aid in determining specific cell clusters involved in regulating the immune microenvironment of HCC. Methods: The scRNA-seq data of 10 HCC samples were collected from the Gene Expression Omnibus (GEO) database GSE124395. Correlations between key gene expression and clinicopathological data were determined using public databases. HCC tissues and matched tumor-adjacent and normal tissue samples were obtained by surgical resection at Sichuan Cancer Hospital. Immune cell infiltration analysis was performed and verified by immunohistochemistry and immunofluorescent staining. Results: Nine malignant hepatocyte clusters with different marker genes and biological functions were identified. C3_Hepatocyte-SERF2 and C6_Hepatocyte-IL13RA2 were mainly involved in the regulation of the immune microenvironment, which was also a significant pathway in regulating HCC metastasis. Key genes in malignant hepatocyte clusters that associated with HCC metastasis were further screened by LASSO regression analysis. TPI1, a key gene in C6_Hepatocyte-IL13RA2 and HCC metastasis, could participate in regulating the HCC immune microenvironment in The Cancer Genome Atlas (TCGA) and Tumor Immune Estimation Resource (TIMER) databases. Moreover, immunohistochemistry analysis demonstrated that TPI1 expression was positively correlated with HCC metastasis and poor prognosis, while negatively correlated with CD8 + T cell infiltration. The negative correlation between TPI1 expression and CD8 + T cell infiltration was further confirmed by immunofluorescence staining. Conclusion: In summary, a cluster of TPI1 + malignant hepatocytes was associated with the suppression of CD8 + T cell infiltration and HCC metastasis, providing novel insights into potential biomarkers for immunotherapy in HCC. Keywords: single-cell RNA sequencing, malignant hepatocyte, hepatocellular carcinoma, immune microenvironment, metastasis Hepatocellular carcinoma (HCC) is one of the most common malignancy and primary liver cancer, with an estimated incidence of more than 1 million by 2025. 1,2 Despite the adoption of promising treatment strategies, including curative resection, transarterial chemoembolization (TACE), molecular targeted therapy, and immunotherapy, the prognosis of HCC remains unsatisfactory. 3,4 The main reasons for poor prognosis in HCC include its propensity for metastasis and recurrence, coupled with the lack of effective predictive and therapeutic strategies. 5,6 Exploring possible factors affecting HCC metastasis and potential treatment options will effectively improve the prognosis of the patients. 5,7 As a typical inflammation-related process in tumorigenesis, immune evasion is an important feature of HCC occurrence and development. 8 Moreover, the tumor microenvironment (TME) in HCC has a strong dependence on the number and status of immune cells, which leads to poor clinical effectiveness of HCC treatment. 9 Therefore, elucidating the role of metastasis-related genes in the immune microenvironment is crucial for the prognosis and treatment strategies of HCC. Due to the highly heterogeneous nature of HCC, its current efficacy is limited. 10 Single-cell RNA sequencing (scRNA-seq) technology could observe the unique characteristics of individual cells and gain insight into the tumor biology, thereby resolving the expression patterns of unique cell populations and enabling studies of the relationship between unique subtypes and HCC. 11,12 The unique ecosystem of HCC tissue contains a variety of -Abstract Truncated-
oncology